Auddia Inc. (NASDAQ: AUUD) has highlighted Influence Healthcare, a healthtech company that uses artificial intelligence and vertical integration to empower surgeons to lead value-based care adoption in high-spend specialties. The announcement comes as Auddia prepares to file its Form S-4 with the Securities and Exchange Commission later this week, advancing the merger process that will combine Auddia with Thramann Holdings, LLC.
Influence Healthcare is designed as an alternative to hospital employment and private-equity rollups, which often reduce physician autonomy or prioritize financial engineering over clinical leadership. The company organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in areas such as spine and total joint surgery. These VBEs are supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics.
Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare, emphasized the importance of physician-led care. "Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care," he said. "Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price."
The platform aims to eliminate administrative drag that makes independent practice difficult. Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney to deploy agentic-AI workflows that automate clinical documentation, coding and billing preparation, episode-of-care validation, prior-authorization, care-pathway adherence monitoring, and communication across the episode. These workflows are designed to reduce the need for multiple full-time administrative staff per surgeon, addressing burnout and rising costs.
Influence Healthcare's model is built around episode-of-care design rather than practice acquisition. It integrates surgeon leadership, facility partners such as ambulatory surgery centers and hospitals, post-acute providers, and AI-enabled care coordination. The company's initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs.
The merger, announced on February 17, 2026, will combine Auddia with Thramann Holdings, which fully owns LT350, Influence Healthcare, and Voyex. Upon completion, Auddia will change its name to McCarthy Finney and trade under the ticker MCFN. McCarthy Finney will serve as an AI holding company delivering AI and Web3 services to its portfolio companies.
For more information about Influence Healthcare, visit www.influencehealthcare.com. Additional details about the merger and Auddia are available at www.auddia.com.
